Volume 22, Issue 1 (4-2026)
J Health Syst Res 2026, 22(1): 165-176 |
Back to browse issues page
Research code: IR.MODARES.REC.1402.111
Ethics code: IR.MODARES.REC.1402.111
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mollabagher M, Hassanzadeh A, Sepehri M M, Habibelahi A, Sarabadani A. Identification and Prioritization of Actors and Stakeholders in the Treatment of Retinopathy of Prematurity in Iran: The Beginning of a Transformation. J Health Syst Res 2026; 22 (1) :165-176
URL: http://hsr.mui.ac.ir/article-1-1975-en.html
URL: http://hsr.mui.ac.ir/article-1-1975-en.html
Maryam Mollabagher1 
, Alireza Hassanzadeh2 , Mohammad Mehdi Sepehri3 , Abbas Habibelahi4 , Abolghasem Sarabadani5
, Alireza Hassanzadeh2 , Mohammad Mehdi Sepehri3 , Abbas Habibelahi4 , Abolghasem Sarabadani5
1- PhD, Department of Information Technology Management, School of Management and Economics, Tarbiat Modares University, Tehran, Iran
2- Professor, Department of Information Technology Management, School of Management and Economics, Tarbiat Modares University, Tehran, Iran
3- Professor, Department of Health Systems Engineering, School of Industrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran
4- Assistant Professor, Tehran university of Medical Sciences, Tehran, Iran
5- Assistant Professor, Department of Information Technology Management, School of Management and Economics, Tarbiat Modares University, Tehran, Iran
2- Professor, Department of Information Technology Management, School of Management and Economics, Tarbiat Modares University, Tehran, Iran
3- Professor, Department of Health Systems Engineering, School of Industrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran
4- Assistant Professor, Tehran university of Medical Sciences, Tehran, Iran
5- Assistant Professor, Department of Information Technology Management, School of Management and Economics, Tarbiat Modares University, Tehran, Iran
Abstract: (174 Views)
Background: The presence of different actors and stakeholders with different interests and expectations in project implementation is one of the issues that presents project managers with serious challenges in managing stakeholders properly. This study was conducted to identify and prioritize the actors and stakeholders in the field of treating retinopathy of prematurity (ROP), as well as to learn about the level of commitment and effectiveness of the stakeholders in treating this disease.
Methods: The present study was conducted in a descriptive-comparative manner and based on the 8-step model of stakeholder analysis using "Kammi Schmeer" method in 4 implementation stages, with initial identification of stakeholders through library studies, open interviews, and then through the distribution of an electronic questionnaire with purposive and convenience sampling among 54 experts in the treatment process in Iran. The data were analyzed using SPSS software.
Findings: The implementation of the research led to the identification of 4 groups of main stakeholders including health management and policymaking, support and implementation, medical service providers, infants and parents, and 23 subgroups in all treatment stages. Further, the level of commitment to creating change and the effectiveness of each of the four groups were investigated. Finally, strategies were presented to advance research goals in the treatment of this disease.
Conclusion: The wide diversity of stakeholders reflects the complexities of the treatment process for ROP in Iran. It also highlights the need for collaboration and partnership as a critical step in designing a national care framework for the various stages of screening, identification, and treatment of this disease.
Methods: The present study was conducted in a descriptive-comparative manner and based on the 8-step model of stakeholder analysis using "Kammi Schmeer" method in 4 implementation stages, with initial identification of stakeholders through library studies, open interviews, and then through the distribution of an electronic questionnaire with purposive and convenience sampling among 54 experts in the treatment process in Iran. The data were analyzed using SPSS software.
Findings: The implementation of the research led to the identification of 4 groups of main stakeholders including health management and policymaking, support and implementation, medical service providers, infants and parents, and 23 subgroups in all treatment stages. Further, the level of commitment to creating change and the effectiveness of each of the four groups were investigated. Finally, strategies were presented to advance research goals in the treatment of this disease.
Conclusion: The wide diversity of stakeholders reflects the complexities of the treatment process for ROP in Iran. It also highlights the need for collaboration and partnership as a critical step in designing a national care framework for the various stages of screening, identification, and treatment of this disease.
Keywords: Retinopathy of prematurity, Stakeholder Analysis, Health Policy, Neonatal Care, Kammi Schmeer, Screening and Diagnosis
Type of Study: Research |
Subject:
education health and promotion
Received: 2025/01/10 | Accepted: 2025/03/9 | Published: 2026/04/4
Received: 2025/01/10 | Accepted: 2025/03/9 | Published: 2026/04/4
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
